Similar articles

• BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.

  Henze G, Fengler R, Hartmann R, Niethammer D, Schellong G, Riehm H. Henze G, et al. Haematol Blood Transfus. 1990;33:619-26. doi: 10.1007/978-3-642-74643-7_113. Haematol Blood Transfus. 1990. PMID: 2182452 Clinical Trial. No abstract available.
• Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials.

  Bührer C, Henze G, Hofmann J, Reiter A, Schellong G, Riehm H. Bührer C, et al. Haematol Blood Transfus. 1990;33:500-3. doi: 10.1007/978-3-642-74643-7_90. Haematol Blood Transfus. 1990. PMID: 2182444 Review.
• Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987.

  Zintl F, Malke H, Reimann M, Dörffel W, Domula M, Eggers G, Exadaktylos P, Kotte W, Krause I, Kunert W, et al. Zintl F, et al. Haematol Blood Transfus. 1990;33:478-82. doi: 10.1007/978-3-642-74643-7_86. Haematol Blood Transfus. 1990. PMID: 2182440 Clinical Trial. No abstract available.
• Results and significance of six randomized trials in four consecutive ALL-BFM studies.

  Riehm H, Gadner H, Henze G, Kornhuber B, Lampert F, Niethammer D, Reiter A, Schellong G. Riehm H, et al. Haematol Blood Transfus. 1990;33:439-50. doi: 10.1007/978-3-642-74643-7_81. Haematol Blood Transfus. 1990. PMID: 2182435 Review. No abstract available.
• Prognosis of initial CNS involvement in acute lymphoblastic leukemia childhood.

  Dörffel W, Zintl F, Malke H, Reuter G, Reimann M. Dörffel W, et al. Haematol Blood Transfus. 1990;33:494-9. doi: 10.1007/978-3-642-74643-7_89. Haematol Blood Transfus. 1990. PMID: 2182443 Clinical Trial. No abstract available.